dalteparin has been researched along with Blue Toe Syndrome in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Blue Toe Syndrome: A condition that is caused by recurring atheroembolism in the lower extremities. It is characterized by cyanotic discoloration of the toes, usually the first, fourth, and fifth toes. Discoloration may extend to the lateral aspect of the foot. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without amputation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Antiphospholipid syndrome is an autoimmune disease characterized by vascular thrombosis involving both the arterial and venous systems that can lead to tissue ischemia or end-organ damage." | 1.51 | The Solitary Blue Toe: A Unique Presentation of Antiphospholipid Syndrome. ( Dimond, DG; Driscoll, K; Kiser, C; Lam, JK; Razzante, M; Wurster, L, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimond, DG | 1 |
| Lam, JK | 1 |
| Wurster, L | 1 |
| Kiser, C | 1 |
| Driscoll, K | 1 |
| Razzante, M | 1 |
1 other study available for dalteparin and Blue Toe Syndrome
| Article | Year |
|---|---|
The Solitary Blue Toe: A Unique Presentation of Antiphospholipid Syndrome.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Blue Toe Syndrome; Computed | 2019 |